Vein to Vein Planning Lead

Updated: March 29, 2024 12:47 AM GMT

Johnson & Johnson

Ghent (+1 other)

CAR-T is an advanced therapy that uses the patient's own immune system to fight the disease. The patient's T-cells are genetically modified to eliminate cancer cells. This cutting-edge, innovative technology offers a hopeful outlook to patients for whom other therapies have no or insufficient effect.

Department: Global Vein to Vein (planning & logistics)

The Vein to Vein (V2V) team is a global team that supports the patient journey of cell therapies from a planning & logistics point of view. We are organized globally with regional sub teams. We partner with many internal and external stakeholders to ensure timely, fast & compliant movement of patient cells across the different supply chain nodes. Currently new manufacturing facilities are being developed in Ghent to treat 12,000 patients a year.

Role: EMEA Vein to Vein Planning Lead

Key to this role will be driving planning and logistics projects to improve our current set up and enhance for scalability. This will require building... More Detail